India, Sept. 4 -- Several biotech and medical device stocks were in focus Friday, including Pro-Dex following strong fiscal 2026 results; Modular Medical after FDA clearance for Pivot patch pump software enhancements; and ENvue Medical following its selection for the Vizient Innovative Technology Exchange. Attovia Therapeutics and Pyxis Oncology also gained after providing clinical and investor updates.
Read on.PRO-DEX INC. (PDEX) reported strong fiscal 2026 fourth-quarter and full-year results, with shares rising more than 16% Friday.
Fourth-quarter net sales increased 17% to $20.41 million from $17.49 million a year earlier, while net income rose to $2.86 million, or $0.87 per share, from $1.20 million, or $0.36 per share.
For fiscal 2...